Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline pharmacokinetics and effectiveness in multidrug-resistant post-craniotomy intracranial infection
ChiCTR-OPN-15005793Phase 4Recruiting
- Sponsor
- Department of Critical Care Medicine, Beijing Tiantan Hospital Affiliated to Capital Medical University
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tigecycline in intracranial infection, sponsored by Department of Critical Care Medicine, Beijing Tiantan Hospital Affiliated to Capital Medical University. Primary endpoints: Serum tigecycline concentration, Cerebrospinal fluid tigecycline concentration and 2 more. Started Jan 2015; status: recruiting.
02
Drugs
tigecycline
03
Conditions
intracranial infection
Beyond the preview
Go deeper on ChiCTR-OPN-15005793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15005793.